Predictions
ElringKlinger AG
Start price
Target price
Perf. (%)
€8.77
31.10.20
31.10.20
-
04.11.21
04.11.21
3.42%
09.11.20
09.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Canadian Solar Inc.
Start price
Target price
Perf. (%)
€30.91
31.10.20
31.10.20
€39.00
04.11.21
04.11.21
8.35%
14.11.20
14.11.20
Could be very worthwhile Investment >20% year
Top 10 in its market
Small cyclical dependencies
Known brand
Highland Gold Mining
Start price
Target price
Perf. (%)
€3.33
30.10.20
30.10.20
-
04.11.21
04.11.21
-0.42%
14.11.20
14.11.20
Could be worthwhile Investment >10% per year
SRP Groupe S.A.
Start price
Target price
Perf. (%)
€1.18
30.10.20
30.10.20
€3.20
04.11.21
04.11.21
73.43%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
miRagen Therapeutics Inc
Start price
Target price
Perf. (%)
€24.75
30.10.20
30.10.20
€45.00
02.11.20
02.11.20
-39.39%
02.11.20
02.11.20
Risky Investment
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.45
29.10.20
29.10.20
-
04.11.21
04.11.21
-0.78%
04.11.20
04.11.20
Could be very worthwhile Investment >20% year
ElringKlinger AG
Start price
Target price
Perf. (%)
€8.53
29.10.20
29.10.20
€10.00
31.10.20
31.10.20
2.81%
31.10.20
31.10.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Cocrystal Pharma Inc.
Start price
Target price
Perf. (%)
€8.64
28.10.20
28.10.20
-
04.11.21
04.11.21
31.94%
15.07.21
15.07.21
Could be very worthwhile Investment >20% year
Kandi Technologies Corp.
Start price
Target price
Perf. (%)
€5.53
28.10.20
28.10.20
€4.70
02.11.20
02.11.20
4.27%
02.11.20
02.11.20
EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€267.50
27.10.20
27.10.20
€300.00
31.10.20
31.10.20
8.41%
31.10.20
31.10.20
Could be worthwhile Investment >10% per year
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€9.45
27.10.20
27.10.20
€8.92
31.10.20
31.10.20
-25.93%
31.10.20
31.10.20
Risky Investment
Inovio Pharma
Start price
Target price
Perf. (%)
€8.90
27.10.20
27.10.20
-
04.11.21
04.11.21
-24.99%
15.07.21
15.07.21
Risky Investment
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.50
27.10.20
27.10.20
-
29.10.20
29.10.20
-0.77%
29.10.20
29.10.20
Could be very worthwhile Investment >20% year
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.60
26.10.20
26.10.20
-
27.10.20
27.10.20
-1.52%
27.10.20
27.10.20
Could be very worthwhile Investment >20% year
Inovio Pharma
Start price
Target price
Perf. (%)
€8.90
26.10.20
26.10.20
-
27.10.20
27.10.20
0.00%
27.10.20
27.10.20
Risky Investment
Inovio Pharma
Start price
Target price
Perf. (%)
€8.95
26.10.20
26.10.20
-
26.10.20
26.10.20
-0.56%
26.10.20
26.10.20
Risky Investment
Inovio Pharma
Start price
Target price
Perf. (%)
€9.25
26.10.20
26.10.20
-
26.10.20
26.10.20
-3.24%
26.10.20
26.10.20
Risky Investment
Borr Drilling Ltd
Start price
Target price
Perf. (%)
€0.71
24.10.20
24.10.20
€1.60
04.11.21
04.11.21
158.58%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€7.00
23.10.20
23.10.20
-
04.11.21
04.11.21
-37.53%
05.11.21
05.11.21
Risky Investment
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€2.10
23.10.20
23.10.20
€1.00
04.11.21
04.11.21
7.62%
04.11.20
04.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Mutares SE & Co. KgaA
Start price
Target price
Perf. (%)
€11.10
22.10.20
22.10.20
€12.00
04.11.21
04.11.21
112.61%
05.11.21
05.11.21
ElringKlinger AG
Start price
Target price
Perf. (%)
€8.24
22.10.20
22.10.20
€18.00
04.11.21
04.11.21
47.57%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued